A NEW POSSIBILITY FOR BODY CONTROL ?

Experts are excitedly investigating retatrutide, a novel drug developed by Eli Lilly, as a significant step in weight management. Distinct from many previous approaches, retatrutide is a twin-action receptor targeting equally GLP-1 and GIP, chemicals that impact hunger and blood glucose regulati